![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/20/2901581/0/en/SAb-Biotherapeutics-Rebrands-as-SAB-BIO.html
https://www.globenewswire.com/news-release/2024/06/18/2900714/0/en/SAB-Biotherapeutics-to-Present-at-the-American-Diabetes-Association-84th-Scientific-Sessions.html
https://www.globenewswire.com/news-release/2024/05/30/2891175/0/en/SAB-Biotherapeutics-Announces-Departure-of-Chief-Financial-Officer.html
https://www.globenewswire.com/news-release/2024/05/21/2885460/0/en/FDA-Provides-Clearance-to-IND-Application-for-Type-1-Diabetes-Therapy-SAB-142-by-SAB-Biotherapeutics.html
https://www.globenewswire.com/news-release/2024/05/20/2885182/0/en/SAB-Biotherapeutics-Announces-Q1-2024-Financial-Results-and-Provides-Company-Updates.html
https://www.globenewswire.com/news-release/2024/05/06/2875703/0/en/SAB-Biotherapeutics-Appoints-Jay-Skyler-MD-to-the-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/04/16/2863478/0/en/SAB-Biotherapeutics-Provides-SAB-142-Trial-Update.html
https://www.globenewswire.com/news-release/2024/04/08/2859075/0/en/SAB-Biotherapeutics-to-Present-at-INNODIA-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/04/04/2857665/0/en/SAB-Biotherapeutics-to-Present-at-the-Needham-Virtual-Healthcare-Conference.html